贝兰他马夫多丁:从临床试验数据到现实生活经验
Sonia Morè1, Massimo Offidani1, Laura Corvatta2
1Clinica di Ematologia Azienda Ospedaliero, Universitaria delle Marche, 60126 Ancona, Italy.
Cancers
|June 10, 2023
概括
一种抗BCMA疗法Belantamab mafodotin在治疗复发性多发性骨髓瘤 (MM) 方面显示出前景. 现实数据证实了它的有效性和安全性,支持在MM患者中进行进一步的研究,这些患者对标准治疗不耐药.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 多发性骨髓瘤 (MM) 尽管在免疫治疗方面取得了进展,但仍然无法治愈.
- 三重耐火性MM呈现出令人丧的结果,需要新的治疗方法.
- 向B细胞成熟抗原 (BCMA) 是一个有前途的策略,因为它在血细胞上表达很高.
研究的目的:
- 为了评估贝兰塔马布 (Belantamab Mafodotin) 的现实有效性和安全性,这是一个针对BCMA的抗体-药物结合物.
- 分析临床试验数据,组合研究,以及贝兰塔马布 (Belantamab Mafodotin) 的多种剂量表.
- 为了鼓励进一步研究贝兰塔马布 (Belantamab Mafodotin) 用于多发性骨髓瘤治疗.
主要方法:
- 对临床试验的审查,包括DREAMM-2第二阶段试验.
- 分析来自全球经验的真实世界数据与Belantamab Mafodotin.
- 探索组合疗法和不同的剂量计划,以优化疗效和毒性.
主要成果:
- 贝兰塔马布 (Belantamab Mafodotin) 在三重耐药MM患者中显示出良好的疗效和安全性.
- 现实世界的数据证实了临床试验的发现.
- 该药物被批准用于三次暴露的MM患者,先前有>4种治疗线,这突显了其临床实用性.
结论:
- 贝兰塔马布 (Belantamab Mafodotin) 代表了治疗复发性和耐火性多发性髓瘤的重大进展.
- 现实世界的证据支持Belantamab Mafodotin的持续调查和应用.
- 需要进一步的研究来优化Belantamab Mafodotin在MM管理中的使用.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.2K
相关概念视频
Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Pharmacovigilance
914
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
914
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
